Starsource Multitrade

Starsource Multitrade Tangible Book Value per Share

The Tangible Book Value per Share of Starsource Multitrade (506365.BO) as of Oct 19, 2026 is 8.60 INR. In the previous year, Tangible Book Value per Share was 87.63 INR — a change of -90.19% (lower).

Tangible Book Value per Share

8.60INR

YoY

-90.19%

Last updated:

Tangible Book Value per Share of Starsource Multitrade is 2026 8.60 INR. Tangible Book Value per Share of Starsource Multitrade was 2025 87.63 INR. It decreases by -90.19% lower compared to the previous year.

The Starsource Multitrade Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2019
68.86 INR
Jan 1, 2020
71.63 INR
Jan 1, 2021
73.30 INR
Jan 1, 2022
77.03 INR
Jan 1, 2023
77.35 INR
Jan 1, 2024
85.35 INR
Jan 1, 2025
87.63 INR
Jan 1, 2026
8.60 INR
The Starsource Multitrade Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
8.60INR-90.19%
87.63INR+2.67%
85.35INR+10.35%
77.35INR+0.41%
77.03INR+5.09%
73.30INR+2.33%
71.63INR+4.02%
68.86INR+2.04%
67.49INR+1.00%
66.82INR+172.88%
24.49INR-28.29%
34.14INR+5.59%
32.34INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Tangible Book Value per Share of Starsource Multitrade is 8.60 INR in 2026.

Tangible Book Value per Share of Starsource Multitrade changed from 87.63 INR to 8.60 INR, representing a -90.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Starsource Multitrade

All Key Metrics — Starsource Multitrade